Clinical Trial Update: [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial update for Ga-68 MTP220 PET assessing biodistribution and potential efficacy in head and neck cancer and pancreatic cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Pancreatic Cancer

Drugs mentioned

• [Ga-68]MTP220 (MTP220)

Snippet

Sponsor: Qiubai Li | Conditions: Head and Neck Cancer, Pancreatic Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING